Answers are grounded in this paper and cite their sources.
A double-blind crossover pilot study was carried out in six patients with Parkinson's disease in order to test the possible therapeutic effect of L-vasopressin after treatment for 1 month with 30 I.U. intranasally daily. The investigation was completed in five cases. No effects was noticed after LVP treatment.
No takes yet. Share an insight, caveat, or question.
John Jensen (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: